Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin-arrestin complexes
AUTOR(ES)
Chuang, Jen-Zen
FONTE
American Society for Clinical Investigation
RESUMO
Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous degenerative eye disease. Mutations at Arg135 of rhodopsin are associated with a severe form of autosomal dominant RP. This report presents evidence that Arg135 mutant rhodopsins (e.g., R135L, R135G, and R135W) are hyperphosphorylated and bind with high affinity to visual arrestin. Mutant rhodopsin recruits the cytosolic arrestin to the plasma membrane, and the rhodopsin-arrestin complex is internalized into the endocytic pathway. Furthermore, the rhodopsin-arrestin complexes alter the morphology of endosomal compartments and severely damage receptor-mediated endocytic functions. The biochemical and cellular defects of Arg135 mutant rhodopsins are distinct from those previously described for class I and class II RP mutations, and, hence, we propose that they be named class III. Impaired endocytic activity may underlie the pathogenesis of RP caused by class III rhodopsin mutations.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=437971Documentos Relacionados
- Rhodopsin mutations in autosomal dominant retinitis pigmentosa.
- Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa.
- Immune complexes in retinitis pigmentosa.
- Simple tests for rhodopsin involvement in retinitis pigmentosa.
- In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa